After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more

StreetInsider2021-12-17

After-Hours Stock Movers: Spruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00. Eloxx Pharma (NASDAQ: ELOX) 7.7% ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Jialatsia
2021-12-17
Jialatsia
Meep
nanehz07
2021-12-17
nanehz07
Like
Vandaluus
2021-12-17
Vandaluus
Looks like RIVN going to see some heavy selling
Bspn
2021-12-17
Bspn
Ok
happymoney
2021-12-17
happymoney
Shocking
- happymoney:
  Shocked
Wanlin
2021-12-17
Wanlin
Like and comment
- Ameliakoh:
  Done
- JackTing:
  Rivian!!

发表看法

442

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2192942001?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-17 07:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2192942001","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more","media":"StreetInsider","content":"<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">网页链接</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19364278><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4135","symbol_name":"资产管理与托管银行","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=19364278","article_id":"2192942001","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2192942001","pubTimestamp":1639697332,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiate","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4135":"资产管理与托管银行","FDX":"联邦快递","SPRB":"Spruce Biosciences, Inc.","BK4007":"制药","BK4211":"区域性银行","BK4099":"汽车制造商","OWL":"Blue Owl Capital Inc.","FOUR":"Shift4 Payments, Inc.","BK4516":"特朗普概念","BK4139":"生物科技","GM":"通用汽车","X":"美国钢铁","ELOX":"Eloxx制药","SCS":"Steelcase Inc.","RIVN":"Rivian Automotive, Inc."},"translate_title":"盘后股票搬运工：云杉生物科学、Rivian、联邦快递、通用汽车等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FDX":0.9,"X":0.9,"SPRB":0.9,"SI":0.9,"SCS":0.9,"RIVN":0.9,"OWL":0.9,"GM":0.9,"FOUR":0.9,"ELOX":0.9,"DWAC":0.9},"content_text":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.\nRivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.\nSteelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.\nFedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.\nShift4 Payments, Inc. (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.\nGeneral Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.\nUnited States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.\nBiomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":690772010,"gmtCreate":1639715137947,"gmtModify":1639715138547,"author":{"id":"4087959350378170","authorId":"4087959350378170","name":"Jialatsia","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Meep","listText":"Meep","text":"Meep","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690772010","repostId":2192942001,"repostType":4,"repost":{"id":"2192942001","pubTimestamp":1639697332,"share":"https://www.laohu8.com/m/news/2192942001?lang=&edition=full","pubTime":"2021-12-17 07:28","market":"us","language":"en","title":"After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2192942001","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiate","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/SPRB\">Spruce Biosciences, Inc.</a> (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>Eloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.</p>\n<p>Rivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.</p>\n<p>Steelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.</p>\n<p>FedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.</p>\n<p><a href=\"https://laohu8.com/S/FOUR\">Shift4 Payments, Inc.</a> (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.</p>\n<p>General Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.</p>\n<p>United States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.</p>\n<p>Biomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19364278><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"X":"美国钢铁","ELOX":"Eloxx制药","OWL":"Blue Owl Capital Inc.","SPRB":"Spruce Biosciences, Inc.","BK4139":"生物科技","FOUR":"Shift4 Payments, Inc.","GM":"通用汽车","BK4516":"特朗普概念","BK4135":"资产管理与托管银行","FDX":"联邦快递","BK4211":"区域性银行","BK4007":"制药","BK4099":"汽车制造商","RIVN":"Rivian Automotive, Inc.","SCS":"Steelcase Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19364278","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192942001","content_text":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.\nRivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.\nSteelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.\nFedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.\nShift4 Payments, Inc. (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.\nGeneral Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.\nUnited States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.\nBiomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690750940,"gmtCreate":1639711725960,"gmtModify":1639711726117,"author":{"id":"4090062734790350","authorId":"4090062734790350","name":"nanehz07","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690750940","repostId":2192942001,"repostType":4,"repost":{"id":"2192942001","pubTimestamp":1639697332,"share":"https://www.laohu8.com/m/news/2192942001?lang=&edition=full","pubTime":"2021-12-17 07:28","market":"us","language":"en","title":"After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2192942001","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiate","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/SPRB\">Spruce Biosciences, Inc.</a> (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>Eloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.</p>\n<p>Rivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.</p>\n<p>Steelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.</p>\n<p>FedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.</p>\n<p><a href=\"https://laohu8.com/S/FOUR\">Shift4 Payments, Inc.</a> (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.</p>\n<p>General Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.</p>\n<p>United States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.</p>\n<p>Biomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19364278><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"X":"美国钢铁","ELOX":"Eloxx制药","OWL":"Blue Owl Capital Inc.","SPRB":"Spruce Biosciences, Inc.","BK4139":"生物科技","FOUR":"Shift4 Payments, Inc.","GM":"通用汽车","BK4516":"特朗普概念","BK4135":"资产管理与托管银行","FDX":"联邦快递","BK4211":"区域性银行","BK4007":"制药","BK4099":"汽车制造商","RIVN":"Rivian Automotive, Inc.","SCS":"Steelcase Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19364278","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192942001","content_text":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.\nRivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.\nSteelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.\nFedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.\nShift4 Payments, Inc. (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.\nGeneral Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.\nUnited States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.\nBiomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690768156,"gmtCreate":1639709964199,"gmtModify":1639709964271,"author":{"id":"4097909991277410","authorId":"4097909991277410","name":"Vandaluus","avatar":"https://static.tigerbbs.com/d67f7b514a0138692caaf51f378ad104","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Looks like&nbsp;RIVN going to see some heavy selling","listText":"Looks like&nbsp;RIVN going to see some heavy selling","text":"Looks like RIVN going to see some heavy selling","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690768156","repostId":2192942001,"repostType":2,"repost":{"id":"2192942001","pubTimestamp":1639697332,"share":"https://www.laohu8.com/m/news/2192942001?lang=&edition=full","pubTime":"2021-12-17 07:28","market":"us","language":"en","title":"After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2192942001","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiate","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/SPRB\">Spruce Biosciences, Inc.</a> (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>Eloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.</p>\n<p>Rivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.</p>\n<p>Steelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.</p>\n<p>FedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.</p>\n<p><a href=\"https://laohu8.com/S/FOUR\">Shift4 Payments, Inc.</a> (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.</p>\n<p>General Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.</p>\n<p>United States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.</p>\n<p>Biomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19364278><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"X":"美国钢铁","ELOX":"Eloxx制药","OWL":"Blue Owl Capital Inc.","SPRB":"Spruce Biosciences, Inc.","BK4139":"生物科技","FOUR":"Shift4 Payments, Inc.","GM":"通用汽车","BK4516":"特朗普概念","BK4135":"资产管理与托管银行","FDX":"联邦快递","BK4211":"区域性银行","BK4007":"制药","BK4099":"汽车制造商","RIVN":"Rivian Automotive, Inc.","SCS":"Steelcase Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19364278","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192942001","content_text":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.\nRivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.\nSteelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.\nFedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.\nShift4 Payments, Inc. (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.\nGeneral Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.\nUnited States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.\nBiomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690709544,"gmtCreate":1639705910540,"gmtModify":1639705910673,"author":{"id":"3582502134655895","authorId":"3582502134655895","name":"Bspn","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690709544","repostId":2192942001,"repostType":4,"repost":{"id":"2192942001","pubTimestamp":1639697332,"share":"https://www.laohu8.com/m/news/2192942001?lang=&edition=full","pubTime":"2021-12-17 07:28","market":"us","language":"en","title":"After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2192942001","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiate","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/SPRB\">Spruce Biosciences, Inc.</a> (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>Eloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.</p>\n<p>Rivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.</p>\n<p>Steelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.</p>\n<p>FedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.</p>\n<p><a href=\"https://laohu8.com/S/FOUR\">Shift4 Payments, Inc.</a> (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.</p>\n<p>General Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.</p>\n<p>United States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.</p>\n<p>Biomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19364278><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"X":"美国钢铁","ELOX":"Eloxx制药","OWL":"Blue Owl Capital Inc.","SPRB":"Spruce Biosciences, Inc.","BK4139":"生物科技","FOUR":"Shift4 Payments, Inc.","GM":"通用汽车","BK4516":"特朗普概念","BK4135":"资产管理与托管银行","FDX":"联邦快递","BK4211":"区域性银行","BK4007":"制药","BK4099":"汽车制造商","RIVN":"Rivian Automotive, Inc.","SCS":"Steelcase Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19364278","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192942001","content_text":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.\nRivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.\nSteelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.\nFedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.\nShift4 Payments, Inc. (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.\nGeneral Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.\nUnited States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.\nBiomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690447235,"gmtCreate":1639705027234,"gmtModify":1639705027598,"author":{"id":"3569807126010989","authorId":"3569807126010989","name":"happymoney","avatar":"https://static.tigerbbs.com/c7b835f693b89bd9b980cc013a40c669","vip":1,"crmLevel":7,"crmLevelSwitch":0},"htmlText":"Shocking","listText":"Shocking","text":"Shocking","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690447235","repostId":2192942001,"repostType":4,"repost":{"id":"2192942001","pubTimestamp":1639697332,"share":"https://www.laohu8.com/m/news/2192942001?lang=&edition=full","pubTime":"2021-12-17 07:28","market":"us","language":"en","title":"After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2192942001","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiate","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/SPRB\">Spruce Biosciences, Inc.</a> (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>Eloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.</p>\n<p>Rivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.</p>\n<p>Steelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.</p>\n<p>FedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.</p>\n<p><a href=\"https://laohu8.com/S/FOUR\">Shift4 Payments, Inc.</a> (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.</p>\n<p>General Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.</p>\n<p>United States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.</p>\n<p>Biomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19364278><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"X":"美国钢铁","ELOX":"Eloxx制药","OWL":"Blue Owl Capital Inc.","SPRB":"Spruce Biosciences, Inc.","BK4139":"生物科技","FOUR":"Shift4 Payments, Inc.","GM":"通用汽车","BK4516":"特朗普概念","BK4135":"资产管理与托管银行","FDX":"联邦快递","BK4211":"区域性银行","BK4007":"制药","BK4099":"汽车制造商","RIVN":"Rivian Automotive, Inc.","SCS":"Steelcase Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19364278","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192942001","content_text":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.\nRivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.\nSteelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.\nFedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.\nShift4 Payments, Inc. (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.\nGeneral Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.\nUnited States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.\nBiomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7017098,"gmtCreate":1639705037892,"gmtModify":1639705037977,"authorId":3569807126010989,"author":{"id":3569807126010989,"authorId":3569807126010989,"name":"happymoney","avatar":"https://static.tigerbbs.com/c7b835f693b89bd9b980cc013a40c669","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690447235,"type":1,"supId":0,"prevId":0,"content":"Shocked","text":"Shocked","html":"Shocked"}],"langContent":"CN"},{"id":690420212,"gmtCreate":1639702862040,"gmtModify":1639702862666,"author":{"id":"3547347450599561","authorId":"3547347450599561","name":"Wanlin","avatar":"https://static.tigerbbs.com/65fdefa6dcf29500b8aa3b61f1f5d7e0","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690420212","repostId":2192942001,"repostType":4,"repost":{"id":"2192942001","pubTimestamp":1639697332,"share":"https://www.laohu8.com/m/news/2192942001?lang=&edition=full","pubTime":"2021-12-17 07:28","market":"us","language":"en","title":"After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2192942001","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiate","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/SPRB\">Spruce Biosciences, Inc.</a> (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>Eloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.</p>\n<p>Rivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.</p>\n<p>Steelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.</p>\n<p>FedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.</p>\n<p><a href=\"https://laohu8.com/S/FOUR\">Shift4 Payments, Inc.</a> (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.</p>\n<p>General Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.</p>\n<p>United States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.</p>\n<p>Biomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19364278><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"X":"美国钢铁","ELOX":"Eloxx制药","OWL":"Blue Owl Capital Inc.","SPRB":"Spruce Biosciences, Inc.","BK4139":"生物科技","FOUR":"Shift4 Payments, Inc.","GM":"通用汽车","BK4516":"特朗普概念","BK4135":"资产管理与托管银行","FDX":"联邦快递","BK4211":"区域性银行","BK4007":"制药","BK4099":"汽车制造商","RIVN":"Rivian Automotive, Inc.","SCS":"Steelcase Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19364278","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192942001","content_text":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.\nRivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.\nSteelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.\nFedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.\nShift4 Payments, Inc. (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.\nGeneral Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.\nUnited States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.\nBiomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7017841,"gmtCreate":1639707501708,"gmtModify":1639707501745,"authorId":3574754838536636,"author":{"id":3574754838536636,"authorId":3574754838536636,"name":"Ameliakoh","avatar":"https://static.tigerbbs.com/4a747ab791603fb0a649736b10ec7454","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690420212,"type":1,"supId":0,"prevId":0,"content":"Done ","text":"Done ","html":"Done "},{"id":7016299,"gmtCreate":1639702884298,"gmtModify":1639702884391,"authorId":3576068436034029,"author":{"id":3576068436034029,"authorId":3576068436034029,"name":"JackTing","avatar":"https://static.tigerbbs.com/a2c7dabda989c569e85d9515b7803d15","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690420212,"type":1,"supId":0,"prevId":0,"content":"Rivian!!","text":"Rivian!!","html":"Rivian!!"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":442,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2192942001"}